On 9 September 2019 the U.S. Food and Drug Administration (FDA or the agency) issued its final guidance document entitled "Acceptance Review for De Novo Classification Requests."
Please see full publication below for more information.
LOADING PDF: If there are any problems, click here to download the file.
